MiMecore Therapeutics is an emerging glycobiologics company developing a novel suite of biomimetic proteoglycan molecules with the potential to provide a ground-breaking therapeutic approach to the restoration and repair of soft and connective tissues of the body damaged through aging and disease.  The Company’s glycotherapeutic strategy presents a biologically innovative platform for restoring and maintaining the structure and function of the dermal extracellular matrix.